Chemoinformaics analysis of 2,3,11,13-Tetrahydrohelenalin
Molecular Weight | 266.337 | nRot | 0 |
Heavy Atom Molecular Weight | 244.161 | nRig | 17 |
Exact Molecular Weight | 266.152 | nRing | 3 |
Solubility: LogS | -1.925 | nHRing | 1 |
Solubility: LogP | 1.298 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 42.9274 |
nHD | 1 | BPOL | 25.5426 |
QED | 0.676 |
Synth | 4.499 |
Natural Product Likeliness | 3.146 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.506 |
Pgp-sub | 0.109 |
HIA | 0.008 |
CACO-2 | -4.656 |
MDCK | 0.000047 |
BBB | 0.981 |
PPB | 0.490661 |
VDSS | 0.756 |
FU | 0.544135 |
CYP1A2-inh | 0.07 |
CYP1A2-sub | 0.343 |
CYP2c19-inh | 0.02 |
CYP2c19-sub | 0.846 |
CYP2c9-inh | 0.013 |
CYP2c9-sub | 0.126 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.268 |
CYP3a4-inh | 0.098 |
CYP3a4-sub | 0.368 |
CL | 9.427 |
T12 | 0.877 |
hERG | 0.052 |
Ames | 0.016 |
ROA | 0.573 |
SkinSen | 0.329 |
Carcinogencity | 0.159 |
EI | 0.199 |
Respiratory | 0.401 |
NR-Aromatase | 0.073 |
Antiviral | Yes |
Prediction | 0.730216 |